Enablex tablets

Official site from Procter and Gamble Pharmaceuticals. Includes patient and prescribing information 12 Apr 2012 Enablex (darifenacin) Drug Safety Labeling Changes March 2012, January 2012, October 2010

Find patient medical information for Enablex oral on WebMD including its uses, side effects and safety, Do not crush or chew extended-release tablets. Doing

Label: ENABLEX - darifenacin tablet, extended release. Label RSS Share. : JavaScript needed for Sharing tools. Share on facebook Share on twitter Bookmark The recommended starting dose of Enablex extended-release tablets is 7.5 mg once daily. Based upon individual response, the dose may be increased to 15 Enablex is an extended-release tablet for oral administration which contains 7.5 mg or 15 mg darifenacin as its hydrobromide salt. The active moiety, darifenacin


ENABLEX (darifenacin) is an extended-release tablet which contains 7.5 mg or 15 time course of ENABLEX 7.5 mg and 15 mg extended-release tablets is Enablex (darifenacin) is used to treat symptoms of overactive bladder. Includes Enablex Do not crush, chew, or break an extended-release tablet. Swallow it

Darifenacin belongs to the family of medications known as antimuscarinics. It is used to relieve 02273217, ENABLEX 7.5MG EXTENDED-RELEASE TABLET Easy to read patient leaflet for Enablex extended-release tablets. Includes indications, proper use, special instructions, precautions, and possible side effects